Clinical Trial Update: CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 CAR-T cell therapy targeting MUC1 is being investigated for glioblastoma, colorectal cancer, and gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Glioblastoma

Drugs mentioned

• MUC1-targeted CAR-T cell therapy

Snippet

Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Conditions: Malignant Glioma of Brain, Colorectal Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN